Floatz logo

P-MPPF

Drug Resistant Epilepsy

Hospices Civils de LyonSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

11 Active assets in the Drug Resistant Epilepsy cohort.

Asset / SponsorPhaseRating
VITAMIN D
DINA KEUMALA SARI
Phase 3BB
Carbamazepine
Dr Cipto Mangunkusumo General Hospital
Phase 4BB
Oxcarbamezapine
Dr Cipto Mangunkusumo General Hospital
Phase 4BB
LAMOTRIGINE
Dr Cipto Mangunkusumo General Hospital
Phase 4BB
Valproic Acid
Dr Cipto Mangunkusumo General Hospital
Phase 4BB

View all 16 →

Same molecule, other indications

P-MPPF is also rated in:

Parkinson diseaseDormant
CC
Indicative ·
40 / 100
View asset →
epilepsyDormant
D
Indicative ·
30 / 100
View asset →
Dravet syndromeDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →